IL-33 contributes to disease severity in Psoriasis-like models of mouse

Add time:09/03/2019    Source:sciencedirect.com

Immune cells infiltrating the psoriatic skin secrete high amounts of pro-inflammatory cytokines IL-17, TNF-α, IL-21 and IL-36 resulting in chronic inflammation. However, the exact cellular and molecular mechanisms have not been fully understood. We report here elevation of IL-33 expression in psoriatic lesions. Studies in imiquimod (IMQ)-induced mice with psoriatic inflammation confirmed a critical role for IL-33 in driving the disease. IL-33 reduces the CD4+ and CD8+ cells, inhibits autophagy in IMQ-treated mouse skin, and promoted tyrosyl phosphorylation of STAT3. Thus, IL-33 appears to be a major risk factor for severity of psoriasis-like skin inflammation. Our findings may open new perspectives for understanding the mechanisms and developing a therapeutic strategy for psoriasis.

We also recommend Trading Suppliers and Manufacturers of Red 33 (cas 1342-94-5). Pls Click Website Link as below: cas 1342-94-5 suppliers

Prev:Preparative separation and identification of novel subsidiary colors of the color additive D&C Red No. 33 (Acid Red 33 (cas 1342-94-5)) using spiral high-speed counter-current chromatography☆
Next:Interleukin-33 reduces neuronal damage and white matter injury via selective microglia M2 polarization after intracerebral hemorrhage in rats)